Funding Opportunities
Funding Opportunities
Current Funding Opportunities
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| There are no funding opportunities at this time. |
Archived Funding Opportunities
- Limited Competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed)
RFA-RM-18-026 - Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed)
RFA-RM-18-027 - Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed)
RFA-18-028 - Request for Information (RFI): Challenges and Opportunities in Extracellular RNA Communication
NOT-RM-17-025 - Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA (U01)
RFA-RM-13-014 - Data Management and Resource Repository (DMRR) on Extracellular RNA (U54)
RFA-RM-12-010 - Reference Profiles of Human Extracellular RNA (U01)
RFA-RM-12-011 - Extracellular RNA Biogenesis, Biodistribution, Uptake, and Effector Function (U19)
RFA-RM-12-012 - Clinical Utility of Extracellular RNA for Biomarker Development (UH2/UH3)
RFA-RM-12-013 - Clinical Utility of Extracellular RNA for Therapy Development (UH2/UH3)
RFA-RM-12-014
Archived Related Funding Initiatives
- The Role of Exosomes in HIV Neuropathogenesis (R01)
RFA-MH-16-100 - The Role of Exosomes in HIV Neuropathogenesis (R21)
RFA-MH-16-110 - Extracellular Vesicles in HIV/AIDS and Substance Abuse (R01)
RFA-DA-15-011 - Extracellular Vesicles in HIV/AIDS and Substance Abuse (R21)
RFA-DA-15-012 - Parkinson's Disease Biomarker Program (PDBP) Discovery Projects (U01)
PAR-14-256 - Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01)
PAR-16-276 - Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21)
PAR-16-277
